{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:01:43Z","timestamp":1786122103556,"version":"build-2736575974"},"reference-count":175,"publisher":"Portland Press Ltd.","issue":"8","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2022\/06305-7 2023\/05099-7 2024\/15154-8 2025\/13426-3"],"award-info":[{"award-number":["2022\/06305-7 2023\/05099-7 2024\/15154-8 2025\/13426-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic cancer, predominantly represented by Pancreatic Ductal Adenocarcinoma (PDAC), is one of the most frequent and deadly types of cancer. In contrast with other types of cancer, for which advances in prevention, early detection, and treatment have contributed to decreasing incidence and mortality, PDAC continues to be rarely diagnosed at early stages of the disease and exhibits a poor prognosis. As a consequence, therapeutic efficacy remains limited, which is reflected in high mortality. Therefore, the development of novel and effective therapeutic strategies against PDAC is urgent. However, a major component limiting therapeutic efficacy is the highly complex PDAC tumor microenvironment (TME), which is composed of cancer-associated fibroblasts, immunosuppressive cells, cancer stem cells, and a dense extracellular matrix, a structural and biochemical scaffold that sustains tumor development and influences several PDAC phenotypes including metabolism, immune infiltration, metastasis, and therapeutic response. The present review focuses on and discusses the key components of the PDAC TME, with particular emphasis on ECM remodeling, stromal components, their impact on tumor progression and therapeutic resistance, and emerging strategies to target these processes.<\/jats:p>","DOI":"10.1042\/bst20260001","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:50:17Z","timestamp":1786089017000},"page":"1079-1094","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting"],"prefix":"10.1042","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5112-9395","authenticated-orcid":false,"given":"Beatriz\u00a0Magalh\u00e3es","family":"Gomes","sequence":"first","affiliation":[{"name":"Laboratory of Comparative and Translational Oncology, Department of Veterinary Medicine, School of Animal Science and Food Engineering, Universidade de S\u00e3o Paulo (USP), Pirassununga, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-9822","authenticated-orcid":false,"given":"Pedro\u00a0Luiz\u00a0Porfirio","family":"Xavier","sequence":"additional","affiliation":[{"name":"Laboratory of Comparative and Translational Oncology, Department of Veterinary Medicine, School of Animal Science and Food Engineering, Universidade de S\u00e3o Paulo (USP), Pirassununga, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2026080703501002600_B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"2026080703501002600_B2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/jso.27462","article-title":"Global trends in the incidence and mortality of pancreatic cancer based on geographic location, socioeconomic status, and demographic shift","volume":"128","author":"Sharma","year":"2023","journal-title":"J. Surg. Oncol."},{"key":"2026080703501002600_B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2019.11.002","article-title":"Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma","volume":"125","author":"Latenstein","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"2026080703501002600_B4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/MPA.0000000000001338","article-title":"Characteristics and outcomes of pancreatic cancer by histological subtypes","volume":"48","author":"Luo","year":"2019","journal-title":"Pancreas"},{"key":"2026080703501002600_B5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2026080703501002600_B6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12672-023-00744-w","article-title":"The tumor\u2013stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma","volume":"14","author":"Lu","year":"2023","journal-title":"Discov. Onc."},{"key":"2026080703501002600_B7","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The interplay between extracellular matrix remodeling and cancer therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"key":"2026080703501002600_B8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s43018-023-00526-x","article-title":"Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy","volume":"4","author":"B\u00e4rthel","year":"2023","journal-title":"Nat. Cancer"},{"key":"2026080703501002600_B9","doi-asserted-by":"publisher","first-page":"19609","DOI":"10.1073\/pnas.1908626116","article-title":"Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells","volume":"116","author":"Tian","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026080703501002600_B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.751311","article-title":"The PDAC extracellular matrix: a review of the ECM protein composition, tumor cell interaction, and therapeutic strategies","volume":"11","author":"Perez","year":"2021","journal-title":"Front. Oncol."},{"key":"2026080703501002600_B11","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.xcrm.2023.101248","article-title":"Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma","volume":"4","author":"Mascharak","year":"2023","journal-title":"Cell Rep. Med."},{"key":"2026080703501002600_B12","doi-asserted-by":"publisher","first-page":"5577.e18","DOI":"10.1016\/j.cell.2021.09.022","article-title":"Spatially confined sub-tumor microenvironments in pancreatic cancer","volume":"184","author":"Gr\u00fcnwald","year":"2021","journal-title":"Cell"},{"key":"2026080703501002600_B13","doi-asserted-by":"publisher","first-page":"e150330","DOI":"10.1172\/jci.insight.150330","article-title":"Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma","volume":"7","author":"Ray","year":"2022","journal-title":"JCI Insight"},{"key":"2026080703501002600_B14","doi-asserted-by":"publisher","first-page":"117.e21","DOI":"10.1016\/j.cell.2018.08.017","article-title":"Extracellular matrix remodeling regulates glucose metabolism through TXNIP destabilization","volume":"175","author":"Sullivan","year":"2018","journal-title":"Cell"},{"key":"2026080703501002600_B15","doi-asserted-by":"publisher","first-page":"eadu2276","DOI":"10.1126\/sciadv.adu2276","article-title":"The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage","volume":"11","author":"Efthymiou","year":"2025","journal-title":"Sci. Adv."},{"key":"2026080703501002600_B16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1186\/s12967-025-06778-8","article-title":"The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"2026080703501002600_B17","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","article-title":"Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer","volume":"21","author":"Whatcott","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"2026080703501002600_B18","doi-asserted-by":"publisher","first-page":"818.e9","DOI":"10.1016\/j.ccell.2022.06.011","article-title":"Oncogenic collagen I homotrimers from cancer cells bind to \u03b13\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B19","doi-asserted-by":"publisher","first-page":"548.e6","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","article-title":"Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome","volume":"610","author":"Su","year":"2022","journal-title":"Nature"},{"key":"2026080703501002600_B21","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1038\/s41467-021-22490-9","article-title":"Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/gutjnl-2020-322744","article-title":"Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism","volume":"71","author":"Sun","year":"2022","journal-title":"Gut"},{"key":"2026080703501002600_B23","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1080\/21655979.2021.1949838","article-title":"Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"key":"2026080703501002600_B24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12967-021-02701-z","article-title":"Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa","volume":"19","author":"Wang","year":"2021","journal-title":"J. Transl Med."},{"key":"2026080703501002600_B25","doi-asserted-by":"publisher","first-page":"jcs259978","DOI":"10.1242\/jcs.259978","article-title":"Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche","volume":"135","author":"Papalazarou","year":"2022","journal-title":"J. Cell Sci."},{"key":"2026080703501002600_B26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/jjco\/hyae118","article-title":"Association of stromal type IV collagen and prognosis in neoadjuvant chemotherapy-treated pancreatic cancer","volume":"54","author":"Nakamura","year":"2024","journal-title":"Jpn. J. Clin. Oncol."},{"key":"2026080703501002600_B27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41416-021-01639-9","article-title":"Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5","volume":"126","author":"Nakajima","year":"2022","journal-title":"Br. J. Cancer"},{"key":"2026080703501002600_B28","doi-asserted-by":"publisher","first-page":"112811","DOI":"10.1016\/j.jphotobiol.2023.112811","article-title":"Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer","volume":"250","author":"Obaid","year":"2024","journal-title":"J. Photochem. Photobiol. B"},{"key":"2026080703501002600_B29","doi-asserted-by":"publisher","first-page":"217898","DOI":"10.1016\/j.canlet.2025.217898","article-title":"CEMIP2 sensitizes PDAC to chemotherapy through extracellular matrix remodeling by hyaluronan degradation","volume":"630","author":"Yao","year":"2025","journal-title":"Cancer Lett."},{"key":"2026080703501002600_B30","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1158\/0008-5472.CAN-19-2578","article-title":"Cancer cell\u2013derived matrisome proteins promote metastasis in pancreatic ductal adenocarcinoma","volume":"80","author":"Tian","year":"2020","journal-title":"Cancer Res."},{"key":"2026080703501002600_B31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41556-022-01055-y","article-title":"Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation","volume":"25","author":"Wu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"2026080703501002600_B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2025.1595523","article-title":"FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K\/AKT signaling","volume":"15","author":"Zhu","year":"2025","journal-title":"Front. Oncol."},{"key":"2026080703501002600_B33","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1111\/cas.15444","article-title":"Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes","volume":"113","author":"Miyahara","year":"2022","journal-title":"Cancer Sci."},{"key":"2026080703501002600_B34","doi-asserted-by":"publisher","first-page":"381428","DOI":"10.5402\/2012\/381428","article-title":"The dual role of TGF\u03b2 in human cancer: from tumor suppression to cancer metastasis","volume":"2012","author":"Lebrun","year":"2012","journal-title":"Int. Scholarly Res. Notices"},{"key":"2026080703501002600_B35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/biom13101551","article-title":"The role of the transforming growth factor-\u03b2 signaling pathway in gastrointestinal cancers","volume":"13","author":"Matsuoka","year":"2023","journal-title":"Biomolecules"},{"key":"2026080703501002600_B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.612271","article-title":"Stroma involvement in pancreatic ductal adenocarcinoma: an overview focusing on extracellular matrix proteins","volume":"12","author":"Liot","year":"2021","journal-title":"Front. Immunol."},{"key":"2026080703501002600_B37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13402-021-00594-0","article-title":"Role of TGF-\u03b2 in pancreatic ductal adenocarcinoma progression and PD-L1 expression","volume":"44","author":"Hussain","year":"2021","journal-title":"Cell. Oncol."},{"key":"2026080703501002600_B38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41419-025-07859-8","article-title":"TGF-\u03b21-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis","volume":"16","author":"Cave","year":"2025","journal-title":"Cell Death Dis."},{"key":"2026080703501002600_B39","doi-asserted-by":"publisher","first-page":"101126","DOI":"10.1016\/j.neo.2025.101126","article-title":"Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdifferentiation","volume":"60","author":"Krauss","year":"2025","journal-title":"Neoplasia"},{"key":"2026080703501002600_B40","doi-asserted-by":"publisher","first-page":"101533","DOI":"10.1016\/j.tranon.2022.101533","article-title":"Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-\u03b2 signal activation in pancreatic ductal adenocarcinoma","volume":"26","author":"Matsumura","year":"2022","journal-title":"Translational Oncol."},{"key":"2026080703501002600_B41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11605-021-05087-x","article-title":"TGF-\u03b2 alters the proportion of infiltrating immune cells in a pancreatic ductal adenocarcinoma","volume":"26","author":"Trebska-McGowan","year":"2022","journal-title":"J. Gastrointest. Surg."},{"key":"2026080703501002600_B42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s42003-022-03994-6","article-title":"SMAD2\/3 mediate oncogenic effects of TGF-\u03b2 in the absence of SMAD4","volume":"5","author":"Bertrand-Chapel","year":"2022","journal-title":"Commun. Biol."},{"key":"2026080703501002600_B43","doi-asserted-by":"publisher","first-page":"eaau8544","DOI":"10.1126\/scisignal.aau8544","article-title":"Chronic TGF-\u03b2 exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition","volume":"12","author":"Katsuno","year":"2019","journal-title":"Sci. Signal."},{"key":"2026080703501002600_B44","doi-asserted-by":"publisher","first-page":"188583","DOI":"10.1016\/j.bbcan.2021.188583","article-title":"Matrix stiffness and its influence on pancreatic diseases","volume":"1876","author":"Zhang","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2026080703501002600_B45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41467-023-35856-y","article-title":"Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B46","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41563-024-01908-x","article-title":"Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids","volume":"23","author":"LeSavage","year":"2024","journal-title":"Nat. Mater."},{"key":"2026080703501002600_B47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actbio.2025.12.020","article-title":"Matrix stiffness shapes transcriptional profiles and drug responses of pancreatic cancer cells","volume":"210","author":"Peerani","year":"2025","journal-title":"Acta Biomater."},{"key":"2026080703501002600_B48","doi-asserted-by":"publisher","first-page":"143.e22","DOI":"10.1016\/j.cell.2025.11.004","article-title":"Membrane potential mediates the cellular response to mechanical pressure","volume":"189","author":"Mukherjee","year":"2026","journal-title":"Cell"},{"key":"2026080703501002600_B49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-017-0005-2","article-title":"Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival","volume":"3","author":"Rozengurt","year":"2018","journal-title":"Sig. Transduct. Target Ther."},{"key":"2026080703501002600_B50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41420-024-02020-4","article-title":"KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1\/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"2026080703501002600_B51","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41419-022-05258-x","article-title":"PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer","volume":"13","author":"Nimmakayala","year":"2022","journal-title":"Cell Death Dis."},{"key":"2026080703501002600_B52","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00535-026-02346-z","article-title":"YAP1-driven tumor-like cancer-associated fibroblasts modulate biomechanics of pancreatic ductal adenocarcinoma","volume":"61","author":"Yang","year":"2026","journal-title":"J. Gastroenterol."},{"key":"2026080703501002600_B53","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1053\/j.gastro.2016.05.006","article-title":"YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK\u2013STAT3 signaling","volume":"151","author":"Gruber","year":"2016","journal-title":"Gastroenterology"},{"key":"2026080703501002600_B54","doi-asserted-by":"publisher","first-page":"16708","DOI":"10.1021\/acsami.5c02296","article-title":"Mapping tumor\u2013stroma\u2013ECM interactions in spatially advanced 3D models of pancreatic cancer","volume":"17","author":"Kataki","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026080703501002600_B55","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-023-00535-3","article-title":"Biomaterial-based platforms for tumour tissue engineering","volume":"8","author":"Curvello","year":"2023","journal-title":"Nat. Rev Mater."},{"key":"2026080703501002600_B56","doi-asserted-by":"publisher","first-page":"e10518","DOI":"10.1002\/btm2.10518","article-title":"Adjustable extracellular matrix rigidity tumor model for studying stiffness dependent pancreatic ductal adenocarcinomas progression and tumor immunosuppression","volume":"8","author":"Zhang","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"2026080703501002600_B57","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41563-024-01908-x","article-title":"Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids","volume":"23","author":"LeSavage","year":"2024","journal-title":"Nat. Mater."},{"key":"2026080703501002600_B58","doi-asserted-by":"publisher","first-page":"e16578","DOI":"10.1002\/advs.202516578","article-title":"GOT1 inhibition induces extracellular matrix remodeling in pancreatic cancer","volume":"13","author":"Curvello","year":"2026","journal-title":"Adv. Sci."},{"key":"2026080703501002600_B59","doi-asserted-by":"publisher","first-page":"101.e11","DOI":"10.1016\/j.ccell.2023.12.002","article-title":"EGFR-activated myofibroblasts promote metastasis of pancreatic cancer","volume":"42","author":"Mucciolo","year":"2024","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B60","doi-asserted-by":"publisher","first-page":"112678","DOI":"10.1016\/j.mce.2025.112678","article-title":"Periostin-positive stellate cells associated with perineural invasion in pancreatic adenocarcinoma","volume":"611","author":"De Carvalho Fraga","year":"2026","journal-title":"Mol. Cell. Endocrinol."},{"key":"2026080703501002600_B61","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1186\/s12967-025-07164-0","article-title":"Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"2026080703501002600_B62","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/gutjnl-2024-333638","article-title":"Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling","volume":"74","author":"Sun","year":"2025"},{"key":"2026080703501002600_B63","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-24-3173","article-title":"Cancer-associated fibroblasts foster a high-lactate microenvironment to drive perineural invasion in pancreatic cancer","volume":"85","author":"Li","year":"2025","journal-title":"Cancer Res."},{"key":"2026080703501002600_B64","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2026080703501002600_B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2021.110227","article-title":"Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion","volume":"38","author":"Murray","year":"2022","journal-title":"Cell Rep."},{"key":"2026080703501002600_B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2021.743907","article-title":"The cellular origins of cancer-associated fibroblasts and their opposing contributions to pancreatic cancer growth","volume":"9","author":"Manoukian","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"2026080703501002600_B67","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1038\/s41598-017-07144-5","article-title":"A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment","volume":"7","author":"Nair","year":"2017","journal-title":"Sci. Rep."},{"key":"2026080703501002600_B68","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"2026080703501002600_B69","doi-asserted-by":"publisher","first-page":"2415196","DOI":"10.1002\/advs.202415196","article-title":"Transcriptome landscape of cancer-associated fibroblasts in human PDAC","volume":"12","author":"Tao","year":"2025","journal-title":"Adv. Sci."},{"key":"2026080703501002600_B70","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-08237-4","article-title":"Multimodal transcriptomics reveal myCAF-derived collagen signaling associated with impaired NK-cell cytotoxicity and immune exclusion in pancreatic cancer","author":"Kong","year":"2026","journal-title":"J. Transl. Med."},{"key":"2026080703501002600_B71","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discovery"},{"key":"2026080703501002600_B72","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"2026080703501002600_B73","first-page":"1","article-title":"Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer","volume":"134","author":"Wang","year":"2025","journal-title":"Br. J. Cancer"},{"key":"2026080703501002600_B74","doi-asserted-by":"publisher","first-page":"656.e7","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","article-title":"Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov."},{"key":"2026080703501002600_B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2024.111612","article-title":"Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"2026080703501002600_B77","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","article-title":"Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov."},{"key":"2026080703501002600_B78","doi-asserted-by":"publisher","first-page":"1080.e11","DOI":"10.1016\/j.ccell.2026.03.004","article-title":"Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer","volume":"44","author":"Kirschstein","year":"2026","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B79","doi-asserted-by":"publisher","first-page":"1677.e15","DOI":"10.1016\/j.ccell.2025.06.021","article-title":"Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B80","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ymthe.2025.01.023","article-title":"Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRASG12D protein to cancer-associated fibroblasts","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther."},{"key":"2026080703501002600_B81","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41467-019-10968-6","article-title":"CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan","volume":"10","author":"Vennin","year":"2019","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B82","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/1878-0261.13442","article-title":"Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways","volume":"17","author":"Chang","year":"2023","journal-title":"Mol. Oncol."},{"key":"2026080703501002600_B83","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","article-title":"Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer","volume":"13","author":"Falcomat\u00e0","year":"2023","journal-title":"Cancer Discov."},{"key":"2026080703501002600_B84","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1200\/JCO.21.02616","article-title":"Immunologic strategies in pancreatic cancer: making cold tumors hot","volume":"40","author":"Ullman","year":"2022","journal-title":"JCO"},{"key":"2026080703501002600_B85","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41467-025-67197-3","article-title":"Targeting TNK2\/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer","volume":"17","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B86","doi-asserted-by":"publisher","first-page":"e0265725","DOI":"10.1371\/journal.pone.0265725","article-title":"Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation","volume":"17","author":"Arnoletti","year":"2022","journal-title":"PloS One"},{"key":"2026080703501002600_B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2023.112620","article-title":"Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"key":"2026080703501002600_B88","doi-asserted-by":"publisher","first-page":"1276.e11","DOI":"10.1016\/j.ccell.2023.04.016","article-title":"Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity","volume":"41","author":"Yan","year":"2023","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B89","doi-asserted-by":"publisher","first-page":"2400836","DOI":"10.1002\/advs.202400836","article-title":"Prolonged survival of neutrophils induced by tumor-derived G-CSF\/GM-CSF promotes immunosuppression and progression in laryngeal squamous cell carcinoma","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci."},{"key":"2026080703501002600_B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00532","article-title":"An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro","volume":"11","author":"Ohms","year":"2020","journal-title":"Front. Immunol."},{"key":"2026080703501002600_B91","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/gutjnl-2021-326070","article-title":"Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment","volume":"72","author":"Wang","year":"2023","journal-title":"Gut"},{"key":"2026080703501002600_B92","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41698-025-01085-3","article-title":"Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma","volume":"9","author":"Zeng","year":"2025","journal-title":"Npj Precis Onc"},{"key":"2026080703501002600_B93","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"2026080703501002600_B94","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s42003-025-08440-x","article-title":"Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis","volume":"8","author":"McDonald","year":"2025","journal-title":"Commun. Biol."},{"key":"2026080703501002600_B95","doi-asserted-by":"publisher","first-page":"1655019","DOI":"10.3389\/fimmu.2025.1655019","article-title":"Neutrophil extracellular traps as drivers of epithelial-mesenchymal transition in cancer cells","volume":"16","author":"Maddalena","year":"2025","journal-title":"Front. Immunol."},{"key":"2026080703501002600_B96","doi-asserted-by":"publisher","first-page":"e1605822","DOI":"10.1080\/2162402X.2019.1605822","article-title":"DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth","volume":"8","author":"Miller-Ocuin","year":"2019","journal-title":"Oncoimmunology"},{"key":"2026080703501002600_B97","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1038\/s41591-024-03075-7","article-title":"Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer","volume":"30","author":"Bojmar","year":"2024","journal-title":"Nat. Med."},{"key":"2026080703501002600_B98","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41416-025-03192-1","article-title":"Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1\/2 pathway promote chemoresistance in pancreatic cancer","volume":"133","author":"Nogi","year":"2025","journal-title":"Br. J. Cancer"},{"key":"2026080703501002600_B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2026.1806714","article-title":"Tumor-associated neutrophils in pancreatic ductal adenocarcinoma: mechanisms and therapeutic targeting","volume":"17","author":"Wu","year":"2026","journal-title":"Front. Immunol."},{"key":"2026080703501002600_B100","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00262-025-03946-z","article-title":"Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone","volume":"74","author":"Yagi","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"2026080703501002600_B101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13046-025-03303-z","article-title":"VSIG4+ tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1","volume":"44","author":"Pan","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2026080703501002600_B102","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1038\/s41467-020-18125-0","article-title":"Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B103","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s42003-024-06087-8","article-title":"Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions","volume":"7","author":"Boelaars","year":"2024","journal-title":"Commun. Biol."},{"key":"2026080703501002600_B104","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B105","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41590-025-02134-6","article-title":"Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer","volume":"26","author":"Shakiba","year":"2025","journal-title":"Nat. Immunol."},{"key":"2026080703501002600_B106","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41591-025-04043-5","article-title":"Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1\/2 trial","volume":"32","author":"Musher","year":"2026","journal-title":"Nat. Med."},{"key":"2026080703501002600_B107","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1002\/cam4.5290","article-title":"Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel","volume":"12","author":"Pegna","year":"2023","journal-title":"Cancer Med."},{"key":"2026080703501002600_B108","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat. Med."},{"key":"2026080703501002600_B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2024.111569","article-title":"CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial","volume":"28","author":"Montagne","year":"2025","journal-title":"iScience"},{"key":"2026080703501002600_B110","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1038\/s41467-023-39196-9","article-title":"A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma","volume":"14","author":"Heumann","year":"2023","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-025-10028-8","article-title":"Tumour\u2013brain crosstalk restrains cancer immunity via a sensory\u2013sympathetic axis","volume":"650","author":"Wei","year":"2026","journal-title":"Nature"},{"key":"2026080703501002600_B112","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41586-025-08735-3","article-title":"Characterization of single neurons reprogrammed by pancreatic cancer","volume":"640","author":"Thiel","year":"2025","journal-title":"Nature"},{"key":"2026080703501002600_B113","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41422-025-01098-4","article-title":"Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells","volume":"35","author":"Wang","year":"2025","journal-title":"Cell Res."},{"key":"2026080703501002600_B114","doi-asserted-by":"publisher","first-page":"eadi0178","DOI":"10.1126\/scitranslmed.adi0178","article-title":"Extracellular vesicle\u2013packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models","volume":"16","author":"Zheng","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"2026080703501002600_B115","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1158\/2159-8290.CD-25-1337","article-title":"Myofibroblasts induce neuroplasticity to promote pancreatic inflammation and cancer progression","volume":"16","author":"Nigri","year":"2026","journal-title":"Cancer Discov."},{"key":"2026080703501002600_B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.192814","article-title":"Sympathetic nerve\u2013fibroblast crosstalk drives nerve injury, fibroblast activation, and matrix remodeling in pancreatic cancer","volume":"11","author":"Sattler","year":"2026","journal-title":"JCI Insight"},{"key":"2026080703501002600_B117","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","article-title":"The \u03b21-adrenergic receptor links sympathetic nerves to T cell exhaustion","volume":"622","author":"Globig","year":"2023","journal-title":"Nature"},{"key":"2026080703501002600_B118","doi-asserted-by":"publisher","first-page":"2241.e8","DOI":"10.1016\/j.ccell.2025.09.003","article-title":"Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses","volume":"43","author":"Ren","year":"2025","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B119","doi-asserted-by":"publisher","first-page":"106555","DOI":"10.1016\/j.phrs.2022.106555","article-title":"Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification","volume":"187","author":"Li","year":"2023","journal-title":"Pharmacol. Res."},{"key":"2026080703501002600_B120","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41565-024-01803-1","article-title":"Targeted intervention in nerve\u2013cancer crosstalk enhances pancreatic cancer chemotherapy","volume":"20","author":"Qin","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"2026080703501002600_B121","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"2026080703501002600_B122","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.biocel.2019.02.002","article-title":"Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance","volume":"109","author":"Brown","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2026080703501002600_B123","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.trecan.2020.12.014","article-title":"The role of the microenvironment and immune system in regulating stem cell fate in cancer","volume":"7","author":"Ferguson","year":"2021","journal-title":"Trends in Cancer"},{"key":"2026080703501002600_B124","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semcancer.2018.08.007","article-title":"Pancreatic cancer stem cells: a state or an entity?","volume":"53","author":"Hermann","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"2026080703501002600_B125","doi-asserted-by":"publisher","first-page":"e0180181","DOI":"10.1371\/journal.pone.0180181","article-title":"The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma","volume":"12","author":"Begum","year":"2017","journal-title":"PloS One"},{"key":"2026080703501002600_B126","doi-asserted-by":"publisher","first-page":"338.e15","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"2026080703501002600_B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2021.109852","article-title":"Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer","volume":"37","author":"Lodestijn","year":"2021","journal-title":"Cell Rep."},{"key":"2026080703501002600_B128","doi-asserted-by":"publisher","first-page":"25489","DOI":"10.1038\/s41598-025-09686-5","article-title":"Induction of cancer stem cells from mouse fibroblasts","volume":"15","author":"Shabrish","year":"2025","journal-title":"Sci. Rep."},{"key":"2026080703501002600_B129","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res."},{"key":"2026080703501002600_B130","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1007\/s11033-019-05058-1","article-title":"Markers of pancreatic cancer stem cells and their clinical and therapeutic implications","volume":"46","author":"Gzil","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"2026080703501002600_B131","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jbior.2019.02.001","article-title":"Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potential","volume":"72","author":"Domenichini","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"2026080703501002600_B132","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41417-025-00896-7","article-title":"The FOXP1-ABCG2 axis promotes the proliferation of cancer stem cells and induces chemoresistance in pancreatic cancer","volume":"32","author":"Hong","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"2026080703501002600_B133","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1038\/s41467-024-47680-z","article-title":"The pRb\/RBL2-E2F1\/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry\/exit by paracrine mechanisms","volume":"15","author":"Chang","year":"2024","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B134","doi-asserted-by":"publisher","first-page":"111407","DOI":"10.1016\/j.intimp.2023.111407","article-title":"Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1","volume":"127","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"2026080703501002600_B135","doi-asserted-by":"publisher","first-page":"1287.e6","DOI":"10.1016\/j.celrep.2019.09.056","article-title":"Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism","volume":"29","author":"Bott","year":"2019","journal-title":"Cell Rep."},{"key":"2026080703501002600_B136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s43018-023-00649-1","article-title":"Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma","volume":"5","author":"Recouvreux","year":"2024","journal-title":"Nat. Cancer"},{"key":"2026080703501002600_B137","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","article-title":"Targeting pancreatic cancer metabolic dependencies through glutamine antagonism","volume":"5","author":"Encarnaci\u00f3n-Rosado","year":"2024","journal-title":"Nat. Cancer"},{"key":"2026080703501002600_B138","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1158\/2767-9764.CRC-21-0147","article-title":"NetrinG1+ cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress","volume":"2","author":"Raghavan","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"2026080703501002600_B139","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.tcb.2025.04.007","article-title":"Tumor\u2013stromal metabolic crosstalk in pancreatic cancer","volume":"35","author":"Thakur","year":"2025","journal-title":"Trends Cell Biol."},{"key":"2026080703501002600_B140","doi-asserted-by":"publisher","first-page":"e50663","DOI":"10.7554\/eLife.50663","article-title":"Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts","volume":"8","author":"Bhagat","year":"2019","journal-title":"eLife"},{"key":"2026080703501002600_B141","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41586-025-08917-z","article-title":"Targeting PIKfyve-driven lipid metabolism in pancreatic cancer","volume":"642","author":"Cheng","year":"2025","journal-title":"Nature"},{"key":"2026080703501002600_B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2024.114972","article-title":"Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment","volume":"43","author":"Han","year":"2024","journal-title":"Cell Rep."},{"key":"2026080703501002600_B143","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12967-024-05598-6","article-title":"Fatty acid oxidation is critical for the tumorigenic potential and chemoresistance of pancreatic cancer stem cells","volume":"22","author":"Mascaraque","year":"2024","journal-title":"J. Transl. Med."},{"key":"2026080703501002600_B144","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"2026080703501002600_B145","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41416-019-0683-3","article-title":"Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma","volume":"122","author":"De Jesus-Acosta","year":"2020","journal-title":"Br. J. Cancer"},{"key":"2026080703501002600_B146","doi-asserted-by":"publisher","first-page":"e35945","DOI":"10.1002\/cncr.35945","article-title":"Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: a randomized clinical trial (AFPAC study)","volume":"131","author":"Ramaswamy","year":"2025","journal-title":"Cancer"},{"key":"2026080703501002600_B147","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026080703501002600_B148","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(11)70004-3","article-title":"Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study","volume":"12","author":"Kindler","year":"2011","journal-title":"Lancet Oncol."},{"key":"2026080703501002600_B149","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/annonc\/mds135","article-title":"BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer","volume":"23","author":"Gon\u00e7alves","year":"2012","journal-title":"Ann. Oncol."},{"key":"2026080703501002600_B150","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/jjco\/hyv011","article-title":"Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial","volume":"45","author":"Ioka","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"key":"2026080703501002600_B151","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/1471-2407-6-285","article-title":"A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer","volume":"6","author":"Friess","year":"2006","journal-title":"BMC Cancer"},{"key":"2026080703501002600_B152","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1158\/1078-0432.CCR-21-1504","article-title":"First-In-Human Phase I Study of a Next-Generation, Oral, TGF\u03b2 Receptor 1 Inhibitor, LY3200882, in patients with advanced cancer","volume":"27","author":"Yap","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"2026080703501002600_B153","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41416-018-0246-z","article-title":"Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer","volume":"119","author":"Melisi","year":"2018","journal-title":"Br. J. Cancer"},{"key":"2026080703501002600_B154","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00280-017-3313-x","article-title":"Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer","volume":"79","author":"Ikeda","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2026080703501002600_B155","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1158\/0008-5472.CAN-23-0104","article-title":"Autotaxin secretion is a stromal mechanism of adaptive resistance to TGF\u03b2 Inhibition in pancreatic ductal adenocarcinoma","volume":"84","author":"Pietrobono","year":"2024","journal-title":"Cancer Res."},{"key":"2026080703501002600_B156","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase alfa With Nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"2026080703501002600_B157","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.18.01295","article-title":"Phase IB\/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313","volume":"37","author":"Ramanathan","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"2026080703501002600_B158","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1158\/1078-0432.CCR-22-0308","article-title":"Defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment refractory pancreatic cancer: a phase I dose escalation and expansion study","volume":"28","author":"Wang-Gillam","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"2026080703501002600_B159","first-page":"1","article-title":"Serplulimab combined with gemcitabine, nab-paclitaxel, and stereotactic body radiotherapy versus gemcitabine and nab-paclitaxel as first-line treatment for recurrent or metastatic pancreatic ductal adenocarcinoma: a randomized, open-label, multicenter, phase III clinical trial (WGOG-PAN 006\/ICSBR-2)","volume":"17","author":"Wang","year":"2026","journal-title":"Front. Immunol."},{"key":"2026080703501002600_B160","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41591-026-04283-z","article-title":"Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial","volume":"32","author":"Wainberg","year":"2026","journal-title":"Nat. Med."},{"key":"2026080703501002600_B161","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1002\/cam4.4768","article-title":"A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond","volume":"11","author":"Noel","year":"2022","journal-title":"Cancer Medicine"},{"key":"2026080703501002600_B162","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s43018-023-00614-y","article-title":"A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer","volume":"4","author":"Chitty","year":"2023","journal-title":"Nat. Cancer"},{"key":"2026080703501002600_B163","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1158\/0008-5472.CAN-23-3933","article-title":"Targeting YAP activity and glutamine metabolism cooperatively suppresses tumor progression by preventing extracellular matrix accumulation","volume":"84","author":"Park","year":"2024","journal-title":"Cancer Res."},{"key":"2026080703501002600_B164","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-23-2994","article-title":"TEAD Inhibition Overcomes YAP1\/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors","volume":"83","author":"Edwards","year":"2023","journal-title":"Cancer Res."},{"key":"2026080703501002600_B165","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.11.483991","article-title":"High throughput screen in a co-culture model to uncover therapeutic strategies to potentiate the cancer-inhibiting properties of the tumor-stroma in pancreatic cancer","author":"Mason","year":"2022","journal-title":"bioRxiv"},{"key":"2026080703501002600_B166","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1038\/s41388-025-03567-x","article-title":"A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer","volume":"44","author":"Wei","year":"2025","journal-title":"Oncogene"},{"key":"2026080703501002600_B167","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.molmed.2023.07.009","article-title":"Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer","volume":"29","author":"Fard","year":"2023","journal-title":"Trends Mol. Med."},{"key":"2026080703501002600_B168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.adp0684","article-title":"Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming","volume":"10","author":"Thielman","year":"2024","journal-title":"Sci. Adv."},{"key":"2026080703501002600_B169","doi-asserted-by":"publisher","first-page":"11246","DOI":"10.1038\/s41467-025-66102-2","article-title":"Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"key":"2026080703501002600_B170","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jconrel.2024.03.041","article-title":"Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model","volume":"369","author":"Tanaka","year":"2024","journal-title":"J. Control. Release"},{"key":"2026080703501002600_B171","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/cas.16418","article-title":"Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer","volume":"116","author":"Wang","year":"2025","journal-title":"Cancer Sci."},{"key":"2026080703501002600_B172","doi-asserted-by":"publisher","first-page":"17211","DOI":"10.1038\/s41598-023-44506-8","article-title":"Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer","volume":"13","author":"Luan","year":"2023","journal-title":"Sci. Rep."},{"key":"2026080703501002600_B173","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.bjc.6600446","article-title":"A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer","volume":"87","author":"Bramhall","year":"2002","journal-title":"Br. J. Cancer"},{"key":"2026080703501002600_B174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2023.107408","article-title":"Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression","volume":"26","author":"Mukherjee","year":"2023","journal-title":"iScience"},{"key":"2026080703501002600_B175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2024.114633","article-title":"A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer","volume":"43","author":"Zheng","year":"2024","journal-title":"Cell Rep."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/54\/8\/1079\/990809\/bst-2026-0001c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/54\/8\/1079\/990809\/bst-2026-0001c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:50:19Z","timestamp":1786089019000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/54\/8\/1079\/237909\/The-tumor-microenvironment-in-pancreatic-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":175,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,7]]},"published-print":{"date-parts":[[2026,8,26]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20260001","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]}}}